Press Releases


Mid Atlantic Bio Angels Initiates Second Investment Pool and Makes Inaugural Investment in POP Medical Solutions, Ltd.

Mid Atlantic Bio Angels Initiates Second Investment Pool and Makes Inaugural Investment in POP Medical Solutions, Ltd. March 13, 2018 09:35 ET | Source: Mid Atlantic Bio Angels   NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on […]


Group K Diagnostics Wins Mid Atlantic Bio Angels’ “Best of the Best” at 1st Pitch Life Science Competition

Group K Diagnostics Wins Mid Atlantic Bio Angels’ “Best of the Best” at 1st Pitch Life Science Competition January 08, 2018 09:35 ET | Source: Mid Atlantic Bio Angels   NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a Philadelphia-based diagnostics company developing a multi-test modular point of care diagnostic platform, was named “Best of the Best” at MABA’s 1st Pitch Life Science event […]


Mid Atlantic Bio Angels Invests in Elysium Therapeutics

Mid Atlantic Bio Angels Invests in Elysium Therapeutics December 20, 2017 11:50 ET | Source: Mid Atlantic Bio Angels   NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that it has made its ninth investment in a company called Elysium Therapeutics, Inc., which is developing a new class of opioid pain relievers that protect individuals from oral misuse, abuse and fatal overdose. “Opioid abuse remains one of the most […]


Mid Atlantic Bio Angels Invests in New View Surgical

Mid Atlantic Bio Angels Invests in New View Surgical November 10, 2017 9:35 ET | Source: Mid Atlantic Bio Angels   NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Boston-based New View Surgical., which has developed a proprietary surgical imaging system for laproscopic surgery.  This is the eighth investment made by MABA since its founding. “Laproscopic and minimally invasive surgeries have become […]


Asulon Therapeutics, Inc. Wins “Best in Show” at Baltimore 1st Pitch Life Science Competition

Asulon Therapeutics, Inc. Wins “Best in Show” at Baltimore 1st Pitch Life Science Competition November 07, 2017 10:00 ET | Source: Mid Atlantic Bio Angels   NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Asulon Therapeutics, Inc., which develops novel small molecules for the treatment of mental health disorders, was named “Best in Show” by the audience at MABA’s 1st Pitch Life Science event held on October 24, 2017 at […]


ColdSteel Laser, Inc. Wins “Best in Show” at 1st Pitch Life Science Competition

ColdSteel Laser, Inc. Wins “Best in Show” at 1st Pitch Life Science Competition October 24, 2017 09:45 ET | Source: Mid Atlantic Bio Angels   NEW YORK, Oct. 24, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that ColdSteel Laser, Inc. (http://www.coldsteellaser.com), which is developing an endoscopic image guided robotic laser scalpel, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science […]


PepVax, Inc. Named “Best in Show” at 1st Pitch PA, October 16, 2017

PepVax, Inc. Wins “Best in Show” at Philadelphia 1st Pitch Life Science Competition October 17, 2017 09:35 ET | Source: Mid Atlantic Bio Angels NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that PepVax, Inc. (http://www.pepvax.co), which is developing a therapeutic treatment against triple negative breast cancer (TNBC), was named “Best in Show” by the investor panel at MABA’s 1st Pitch Life Science event held on October 5, 2017 […]


Mid Atlantic Bio Angels Invests in PainQx, Inc.

Mid Atlantic Bio Angels Invests in PainQx, Inc. Sept 08, 2017 | Source: Mid Atlantic Bio Angels NEW YORK, Sept. 08, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in New York and Philadelphia-based PainQx, Inc., which has developed an accurate and objective method to measure chronic and acute pain in humans. “Pain has long been subjective measurement, whether for hospitals, neurologists or other professionals working […]


Mid Atlantic Bio Angels Portfolio Company, Cerus Endovascular, Receives CE Mark for its Contour Neurovascular System for the Treatment of Intra-Cranial Aneurysms

Mid Atlantic Bio Angels Portfolio Company, Cerus Endovascular, Receives CE Mark for its Contour Neurovascular System for the Treatment of Intra-Cranial Aneurysms July 10, 2017 | Source: Mid Atlantic Bio Angels NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) — Cerus Endovascular Ltd., one of Mid Atlantic Bio Angels’ (MABA) portfolio companies, recently announced receipt of CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across […]


Recensa Therapeutics Wins “Best in Show” at 1st Pitch Life Science Competition NYC

Recensa Therapeutics was named“Best in Show” and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science NYC competition May 25, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis treatment designed to reduce oxidative stress, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at […]